DIN 02265435 — NOVOMIX 30 30 UNIT; 70 UNIT
NOVOMIX 30 is a suspension of Insulin Aspart Protamine / Insulin Aspart marketed by NOVO NORDISK CANADA INC. The full Insulin Aspart Protamine / Insulin Aspart monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02265435
- Brand name
- NOVOMIX 30
- Active ingredient
- Insulin Aspart Protamine / Insulin Aspart
- Strength
- 30 UNIT; 70 UNIT
- Dosage form
- SUSPENSION
- Route
- SUBCUTANEOUS
- Manufacturer
- NOVO NORDISK CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Premixed rapid-acting insulin analogue (biphasic insulin aspart)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.